We’re making history, one milestone at a time
Follow our progress as we work toward our vision of improving outcomes for people with cancer.
Recent News
September 15, 2020
Tizona Appoints Christine O’Brien as Chief Executive Officer
July 21, 2020
Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million.
June 25, 2020
Tizona Initiates Clinical Development of TTX-080 in Advanced Cancers
February 19, 2020
Tizona to Present at The Cowen and Company 40th Annual Healthcare Conference
November 07, 2019
Tizona Announces Publication in Cancer Discovery Highlighting the Important Role of CD39 and Extracellular ATP in Inflammasome-driven Anti-Tumor Immunity
July 11, 2019
Tizona Appoints Joyson Karakunnel, MD, MSc, FACP as Senior Vice President and Chief Medical Officer
May, 15, 2019
Tizona Elects Daniel K. Spiegelman to Its Board of Directors